Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women

NCT00326248 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

482

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea and Vomiting, Postoperative

Interventions

DRUG: GW679769 (casopitant)

Sponsor

GlaxoSmithKline